[
  {
    "ts": null,
    "headline": "BlackRock Global Dividend Fund Q4 2024 Commentary",
    "summary": "BlackRock Global Dividend Fund posted returns of -4.66% (Institutional shares) and -4.64% (Investor A shares, without sales charge) for the fourth quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=fe11fccefad920397ae12f7f4e4eda84c9f64cb98b126478d861edcec76868c3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742419260,
      "headline": "BlackRock Global Dividend Fund Q4 2024 Commentary",
      "id": 133263378,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/96502248/image_96502248.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "BlackRock Global Dividend Fund posted returns of -4.66% (Institutional shares) and -4.64% (Investor A shares, without sales charge) for the fourth quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=fe11fccefad920397ae12f7f4e4eda84c9f64cb98b126478d861edcec76868c3"
    }
  },
  {
    "ts": null,
    "headline": "Mag 7, tech weakness is breeding new opportunities: Where to look",
    "summary": "Meta Platforms (META) has erased its year-to-date gains, making it the final component of the Magnificent Seven group of tech stocks to turn negative in 2025. Where exactly are investors finding new opportunities as this might be a signal for them to pivot away from Big Tech? Aptus Capital Advisors portfolio manager David Wagner underlines the push to diversify into small-cap stocks, while naming some alternatives to mega-cap tech names in other sectors. To watch more expert insights and analysis on the latest market action, check out more Wealth here.",
    "url": "https://finnhub.io/api/news?id=f1150dd31ee0a832dacaf70ab47e03b400742706c830bcbe5f91df04045855af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742399429,
      "headline": "Mag 7, tech weakness is breeding new opportunities: Where to look",
      "id": 133307454,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Meta Platforms (META) has erased its year-to-date gains, making it the final component of the Magnificent Seven group of tech stocks to turn negative in 2025. Where exactly are investors finding new opportunities as this might be a signal for them to pivot away from Big Tech? Aptus Capital Advisors portfolio manager David Wagner underlines the push to diversify into small-cap stocks, while naming some alternatives to mega-cap tech names in other sectors. To watch more expert insights and analysis on the latest market action, check out more Wealth here.",
      "url": "https://finnhub.io/api/news?id=f1150dd31ee0a832dacaf70ab47e03b400742706c830bcbe5f91df04045855af"
    }
  },
  {
    "ts": null,
    "headline": "Is UnitedHealth Stock Still a Buy Despite Its Premium Price Tag?",
    "summary": "UNH is making significant investments in AI and digital tools to enhance consumer experiences and streamline healthcare processes.",
    "url": "https://finnhub.io/api/news?id=9a415f920fb8c2ae3d5fae579c4e5beb138ce8a19fbbe9e54b8f89aa2162cb8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742396880,
      "headline": "Is UnitedHealth Stock Still a Buy Despite Its Premium Price Tag?",
      "id": 133324484,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "UNH is making significant investments in AI and digital tools to enhance consumer experiences and streamline healthcare processes.",
      "url": "https://finnhub.io/api/news?id=9a415f920fb8c2ae3d5fae579c4e5beb138ce8a19fbbe9e54b8f89aa2162cb8e"
    }
  },
  {
    "ts": null,
    "headline": "Is UnitedHealth Group Incorporated (UNH) the Top Stock to Buy According to Marshall Wace LLP?",
    "summary": "We recently published a list of Top 10 Stocks to Buy According to Marshall Wace LLP. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other top stocks to buy according to Marshall Wace LLP. Marshall Wace LLP is a prominent British hedge fund established in 1997 […]",
    "url": "https://finnhub.io/api/news?id=e9be74a11eaa2e30ca42c7436b051b14247bc00a5f144c13c0c92fea91aa8434",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742395539,
      "headline": "Is UnitedHealth Group Incorporated (UNH) the Top Stock to Buy According to Marshall Wace LLP?",
      "id": 133324485,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "We recently published a list of Top 10 Stocks to Buy According to Marshall Wace LLP. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other top stocks to buy according to Marshall Wace LLP. Marshall Wace LLP is a prominent British hedge fund established in 1997 […]",
      "url": "https://finnhub.io/api/news?id=e9be74a11eaa2e30ca42c7436b051b14247bc00a5f144c13c0c92fea91aa8434"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth eases rules on renewing some prescription drugs",
    "summary": "(Reuters) -UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ease requirements to get insurance authorization when renewing prescriptions on about 80 drugs, aiming to reduce paperwork for patients and doctors.  The list, which could be expanded over time, will eliminate up to 25% of reauthorization requirements and accounts for more than 10% of all such pharmacy authorizations, it said.  The program starts on May 1 and will include drugs ranging from Amgen's migraine treatment Aimovig, Vertex Pharmaceutical's cystic fibrosis treatment Kalydeco, and Regeneron's Praluent for high cholesterol.",
    "url": "https://finnhub.io/api/news?id=df1cf77b7b3d57ca0fd29f32cab87c40d9c89d7921597b95f6b4fe16a7864fc0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742382438,
      "headline": "UnitedHealth eases rules on renewing some prescription drugs",
      "id": 133324486,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "(Reuters) -UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ease requirements to get insurance authorization when renewing prescriptions on about 80 drugs, aiming to reduce paperwork for patients and doctors.  The list, which could be expanded over time, will eliminate up to 25% of reauthorization requirements and accounts for more than 10% of all such pharmacy authorizations, it said.  The program starts on May 1 and will include drugs ranging from Amgen's migraine treatment Aimovig, Vertex Pharmaceutical's cystic fibrosis treatment Kalydeco, and Regeneron's Praluent for high cholesterol.",
      "url": "https://finnhub.io/api/news?id=df1cf77b7b3d57ca0fd29f32cab87c40d9c89d7921597b95f6b4fe16a7864fc0"
    }
  },
  {
    "ts": null,
    "headline": "Optum Rx Further Simplifies Consumer Access to Prescription Drugs",
    "summary": "March 19, 2025--Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience simpler for consumers with chronic conditions, eliminating up to 25% of reauthorizations, which is equal to more than 10% of overall pharmacy prior authorizations.",
    "url": "https://finnhub.io/api/news?id=e9217386b499e17f1dfb084df7685c34381a5dceae81df6e6f51f4ef23c2597f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742382000,
      "headline": "Optum Rx Further Simplifies Consumer Access to Prescription Drugs",
      "id": 133324487,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "March 19, 2025--Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience simpler for consumers with chronic conditions, eliminating up to 25% of reauthorizations, which is equal to more than 10% of overall pharmacy prior authorizations.",
      "url": "https://finnhub.io/api/news?id=e9217386b499e17f1dfb084df7685c34381a5dceae81df6e6f51f4ef23c2597f"
    }
  },
  {
    "ts": null,
    "headline": "Optum Rx says it will eliminate 10% of prior authorizations",
    "summary": "The massive pharmacy benefit manager plans to stop requiring coverage reauthorizations for roughly 80 drugs used to treat migraines, multiple sclerosis, high cholesterol and more.",
    "url": "https://finnhub.io/api/news?id=a7cd7fcbb2a448ed27404e140a97af3ff8fddd61bfc6b8f338550990201c9243",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742374015,
      "headline": "Optum Rx says it will eliminate 10% of prior authorizations",
      "id": 133324488,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "The massive pharmacy benefit manager plans to stop requiring coverage reauthorizations for roughly 80 drugs used to treat migraines, multiple sclerosis, high cholesterol and more.",
      "url": "https://finnhub.io/api/news?id=a7cd7fcbb2a448ed27404e140a97af3ff8fddd61bfc6b8f338550990201c9243"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth's unit reduces renewal requirements for some prescription drugs",
    "summary": "UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ease requirements to get insurance authorization when renewing prescriptions on about 80 drugs, aiming to reduce...",
    "url": "https://finnhub.io/api/news?id=7e69c7c2580b4533684e66a09a07c7134a5d6a16987817071a692fe7c49a48b8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742373275,
      "headline": "UnitedHealth's unit reduces renewal requirements for some prescription drugs",
      "id": 133239722,
      "image": "",
      "related": "UNH",
      "source": "Finnhub",
      "summary": "UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ease requirements to get insurance authorization when renewing prescriptions on about 80 drugs, aiming to reduce...",
      "url": "https://finnhub.io/api/news?id=7e69c7c2580b4533684e66a09a07c7134a5d6a16987817071a692fe7c49a48b8"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth's Pharmacy Unit Cuts Drug Reauthorizations to Ease Access",
    "summary": "By Dean Seal UnitedHealth Group's pharmacy business, Optum Rx, said it is eliminating up to 25% of reauthorizations for prescription drugs to simplify access for consumers. Optum said...",
    "url": "https://finnhub.io/api/news?id=93883790e6feba9453fcfe9e6b88a76f6808765b332e27b7949295079cc1148f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742371341,
      "headline": "UnitedHealth's Pharmacy Unit Cuts Drug Reauthorizations to Ease Access",
      "id": 133239525,
      "image": "",
      "related": "UNH",
      "source": "Finnhub",
      "summary": "By Dean Seal UnitedHealth Group's pharmacy business, Optum Rx, said it is eliminating up to 25% of reauthorizations for prescription drugs to simplify access for consumers. Optum said...",
      "url": "https://finnhub.io/api/news?id=93883790e6feba9453fcfe9e6b88a76f6808765b332e27b7949295079cc1148f"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth's unit reduces prescription reauthorization requirements by up to 25%",
    "summary": "UnitedHealth Group said onWednesday its pharmacy benefit manager, Optum Rx, wouldeliminate up to 25% of the annual reauthorization requirementsfor certain drugs, in an effort to reduce the...",
    "url": "https://finnhub.io/api/news?id=4122670bff601883f1182dba31beaafe54fdf7665699e97573db4399b703fb50",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742368724,
      "headline": "UnitedHealth's unit reduces prescription reauthorization requirements by up to 25%",
      "id": 133239288,
      "image": "",
      "related": "UNH",
      "source": "Finnhub",
      "summary": "UnitedHealth Group said onWednesday its pharmacy benefit manager, Optum Rx, wouldeliminate up to 25% of the annual reauthorization requirementsfor certain drugs, in an effort to reduce the...",
      "url": "https://finnhub.io/api/news?id=4122670bff601883f1182dba31beaafe54fdf7665699e97573db4399b703fb50"
    }
  }
]